Skip to content
VuFind
    • English
    • Deutsch
    • Español
    • Français
    • Italiano
    • 日本語
    • Nederlands
    • Português
    • Português (Brasil)
    • 中文(简体)
    • 中文(繁體)
    • Türkçe
    • עברית
    • Gaeilge
    • Cymraeg
    • Ελληνικά
    • Català
    • Euskara
    • Русский
    • Čeština
    • Suomi
    • Svenska
    • polski
    • Dansk
    • slovenščina
    • اللغة العربية
    • বাংলা
    • Galego
    • Tiếng Việt
    • Hrvatski
    • हिंदी
    • Հայերէն
    • Українська
    • Sámegiella
    • Монгол
Advanced
  • The H/R FcγRIIA-131 polym...
  • Cite this
  • Text this
  • Email this
  • Print
  • Export Record
    • Export to RefWorks
    • Export to EndNoteWeb
    • Export to EndNote
  • Permanent link
The H/R FcγRIIA-131 polymorphism and survival in patients with diffuse large B-cell lymphoma (DLBCL) treated with R-CHOP: a study in a genetically mixed population

The H/R FcγRIIA-131 polymorphism and survival in patients with diffuse large B-cell lymphoma (DLBCL) treated with R-CHOP: a study in a genetically mixed population

Bibliographic Details
Main Authors: Débora Levy, Marcelo Bellesso, Pamela Oliveira-Souza, Felipe V. Maciel, Juliana Pereira, Sérgio P. Bydlowski
Format: Article
Language:English
Published: Elsevier España 2011-01-01
Series:Clinics
Online Access:http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1807-59322011000500034
  • Holdings
  • Description
  • Similar Items
  • Staff View

Internet

http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1807-59322011000500034

Similar Items

  • Association of FcγRIIa R131H polymorphism with idiopathic pulmonary fibrosis severity and progression
    by: Hirani Nikhil, et al.
    Published: (2010-10-01)
  • FCγRIIIA and FCγRIIA polymorphisms are not associated with response to rituximab and CHOP in patients with diffuse large B-cell lymphoma
    by: Zdravko Mitroviç, et al.
    Published: (2007-07-01)
  • FcγRIIIA and FcγRIIA polymorphisms do not predict clinical outcome of follicular non-Hodgkin’s lymphoma patients treated with sequential CHOP and rituximab
    by: Emanuela Carlotti, et al.
    Published: (2007-08-01)
  • Serpentine Supravenous Hyperpigmentation in an HIV Patient Receiving R-CHOP for DLBCL
    by: Guido Lancman, et al.
    Published: (2018-01-01)
  • Association of FCγRIIA (CD32) polymorphism with susceptibility to brucellosis
    by: Zahra Hosseini khah, et al.
    Published: (2014-08-01)

Search Options

  • Search History
  • Advanced Search

Find More

  • Browse the Catalog
  • Browse Alphabetically
  • Explore Channels
  • Course Reserves
  • New Items

Need Help?

  • Search Tips
  • Ask a Librarian
  • FAQs